Fig 1: Dex protected hepatic I/R injury in vivo. The rat model of hepatic I/R was established. A, miR-494 and JUND expression was detected using RT-qPCR. B, The levels of ALT and AST in serum of rats were detected using ELISA. C, The rat liver sections were stained with HE staining. D, The rat liver sections were stained with immunohistochemical staining. E, The changes of JUND, p-AKT, AKT, Nrf2 and NLRP3 were detected using Western blotting. N = 6. Data were presented as mean ± standard deviation and analysed using one-way ANOVA, followed by Tukey's multiple comparison test, *** p < 0.001
Fig 2: (A,B) Liver/tibia ratio, (C,D) plasma levels of aspartate aminotransferase (AST), (E,F) plasma levels of alanine transaminase (ALT), and (G,H) ratio of AST/ALT from sedentary (SED) or exercise-preconditioned (EX) male (left) and female (right) rats treated with doxorubicin (DOX) or saline. Data are presented as mean ± SEM. Two-way ANOVA differences are indicated below the graphs. Circles indicate individual data points. * = significant difference between groups (p < 0.05). ** = significant difference between groups (p < 0.01), *** = significant difference between groups (p < 0.001).
Supplier Page from Abcam for Rat AST ELISA Kit (Aspartate Aminotransferase)